Dyno Nobel (DNL) H2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2026 earnings summary
9 Nov, 2026Executive summary
FY26 underlying explosives EBIT rose 12% to AU$485.1m; transformation delivered AU$51m in benefits and reached a 70% exit run rate against the AU$300m ambition.
The Phosphate Hill sale completed the Fertilisers separation, transitioning to a pure-play explosives business.
FY27 underlying EBIT guidance is AU$515m–AU$555m; the FY28 EBIT ambition remains AU$600m.
Financial highlights
Statutory revenue was AU$3,941m, down 26% YoY; EBITDA excluding IMIs was AU$778m and EBIT excluding IMIs was AU$504m.
Explosives revenue rose 10% to AU$3,406.2m; underlying EBITDA was AU$759.4m, up 8%, and underlying EBIT was AU$485.1m, up 12%.
NPAT excluding IMIs was AU$331.6m; statutory profit after tax was AU$66.1m versus a AU$53.2m loss in FY25. After-tax IMIs were AU$265m.
Excluding FX, explosives revenue grew 14% and EBIT excluding IMIs increased 16%.
Outlook and guidance
FY27 underlying EBIT guidance is AU$515m–AU$555m, with ~40% expected in H1 and ~60% in H2; guidance adds back expected ~AU$25m of Cheyenne and QNP turnaround impacts.
FY27 transformation benefits are forecast at AU$30m–AU$70m, with an 85%–95% exit run rate against the AU$300m ambition.
FY27 assumptions include AUD:USD 0.70, borrowing costs of AU$105m–AU$120m, tax of 20%–25%, and net debt/EBITDA near the top of the 1.75x–2.25x target range.
FY28 and FY31 EBIT ambitions are AU$600m and AU$800m, respectively; FY31 includes an estimated AU$30m–AU$40m contribution from North American energetics. These are ambitions, not guidance.
Latest events from Dyno Nobel
- Targeting AUD 800 million EBIT by 2031, driven by technology, defense energetics, and global expansion.DNL
Investor Day 2026 - EBIT up 39% and NPAT ex IMIs up 83% YoY; FY26 EBIT guidance and buyback progress reaffirmed.DNL
H1 2026 - Strong financial results, strategic transformation, and robust shareholder support defined the AGM.DNL
AGM 2025 - FY25 EBIT ex IMIs up 23%, $579m asset sale cash, $1.4bn capital return, FY26 EBIT $460m–$500m.DNL
H2 2025 - Transformation strategy targets doubling EBIT, global growth, and disciplined capital returns.DNL
Investor Showcase 2024 - Record underlying EBIT growth and transformation offset statutory loss from impairments.DNL
H2 2024 - Fertilizer sale talks ended; AUD 900m buyback begins, with 2024 outlook reaffirmed.DNL
Investor Update - Transformation and asset sales drive return to profit and strong 2H outlook.DNL
H1 2025